{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:14:56Z","timestamp":1770142496890,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We retrospectively evaluated surgical outcomes of suture trabeculotomy (SLOT) ab interno for secondary glaucoma in 18 eyes of 12 patients with hereditary transthyretin (ATTRv) amyloidosis with Val30Met mutation. SLOT ab interno was performed between May 2015 and January 2020. All the participants were followed up for at least 12\u00a0months. The primary outcome measure was Kaplan\u2013Meier survival. Failure of this treatment was defined as an intraocular pressure (IOP) of\u2009\u2265\u200922\u00a0mmHg and a\u2009&lt;\u200920% IOP reduction with or without medication or as additional operations needed to reduce IOP. The mean postoperative follow-up period was 3.5\u00a0years (1.2\u20136.1\u00a0years). The SLOT ab interno procedure alone was performed in 17 eyes (94%). Fifteen eyes (83%) had a 360\u00b0 incision made in Schlemm\u2019s canal and 3 eyes (17%) had a 180\u00b0 incision performed. Cumulative survival values were 0.83, 0.63, and 0.22 at 1, 2, and 3\u00a0years, respectively. Ten eyes (56%) needed additional surgery, such as repeated SLOT ab interno, Ahmed glaucoma valve implantation, or MicroPulse transscleral cyclophotocoagulation. Our results here, as well as our previous results with trabeculectomy, suggest that SLOT ab interno may not have a sufficiently long-term effect on secondary glaucoma because of ATTRv amyloidosis.<\/jats:p>","DOI":"10.1038\/s41598-022-23150-8","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T15:33:02Z","timestamp":1668180782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Suture trabeculotomy ab interno for secondary glaucoma in Japanese patients with Val30Met hereditary transthyretin amyloidosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Takahiro","family":"Kawaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"23150_CR1","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","volume":"268","author":"D Adams","year":"2021","unstructured":"Adams, D. et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J. Neurol. 268, 2109\u20132122 (2021).","journal-title":"J. Neurol."},{"key":"23150_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/mus.26034","volume":"57","author":"HH Schmidt","year":"2018","unstructured":"Schmidt, H. H. et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve 57, 829\u2013837 (2018).","journal-title":"Muscle Nerve"},{"key":"23150_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-019-1000-1","volume":"14","author":"M Waddington-Cruz","year":"2019","unstructured":"Waddington-Cruz, M. et al. Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: A global case series. Orphanet J. Rare Dis. 14, 34 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"23150_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0039-6257(95)80025-5","volume":"40","author":"O Sandgren","year":"1995","unstructured":"Sandgren, O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv. Ophthalmol. 40, 173\u2013196 (1995).","journal-title":"Surv. Ophthalmol."},{"key":"23150_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/bjo.81.4.295","volume":"81","author":"E Ando","year":"1997","unstructured":"Ando, E. et al. Ocular manifestations of familial amyloidotic polyneuropathy type I: Long-term follow up. Br. J. Ophthalmol. 81, 295\u2013298 (1997).","journal-title":"Br. J. Ophthalmol."},{"key":"23150_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ajo.2017.09.001","volume":"183","author":"MM Reynolds","year":"2017","unstructured":"Reynolds, M. M. et al. Ocular manifestations of familial transthyretin amyloidosis. Am. J. Ophthalmol. 183, 156\u2013162 (2017).","journal-title":"Am. J. Ophthalmol."},{"key":"23150_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0002-9394(02)01838-X","volume":"135","author":"T Koga","year":"2003","unstructured":"Koga, T. et al. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. Am. J. Ophthalmol. 135, 188\u2013193 (2003).","journal-title":"Am. J. Ophthalmol."},{"key":"23150_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/archophthalmol.2009.390","volume":"128","author":"R Hara","year":"2010","unstructured":"Hara, R. et al. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Arch. Ophthalmol. 128, 206\u2013210 (2010).","journal-title":"Arch. Ophthalmol."},{"key":"23150_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/archopht.121.3.351","volume":"121","author":"A Kimura","year":"2003","unstructured":"Kimura, A. et al. Secondary glaucoma in patients with familial amyloidotic polyneuropathy. Arch. Ophthalmol. 121, 351\u2013356 (2003).","journal-title":"Arch. Ophthalmol."},{"key":"23150_CR10","first-page":"289","volume":"28","author":"R Futa","year":"1984","unstructured":"Futa, R. et al. Familial amyloidotic polyneuropathy: Ocular manifestations with clinicopathological observation. Jpn. J. Ophthalmol. 28, 289\u2013298 (1984).","journal-title":"Jpn. J. Ophthalmol."},{"key":"23150_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF00920934","volume":"231","author":"AC Silva-Araujo","year":"1993","unstructured":"Silva-Araujo, A. C. et al. Aqueous outflow system in familial amyloidotic polyneuropathy, Portuguese type. Graefes Arch. Clin. Exp. Ophthalmol. 231, 131\u2013135 (1993).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"23150_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/13506129.2012.710669","volume":"19","author":"NM Beir\u00e3o","year":"2012","unstructured":"Beir\u00e3o, N. M. et al. Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients. Amyloid 19, 146\u2013151 (2012).","journal-title":"Amyloid"},{"key":"23150_CR13","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1038\/s41598-020-62559-x","volume":"10","author":"S Kakihara","year":"2020","unstructured":"Kakihara, S. et al. Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis. Sci. Rep. 10, 5574 (2020).","journal-title":"Sci. Rep."},{"key":"23150_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096324","volume":"9","author":"T Kawaji","year":"2014","unstructured":"Kawaji, T. et al. Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy. PLoS ONE 9, e96324 (2014).","journal-title":"PLoS ONE"},{"key":"23150_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/eye.1992.71","volume":"6","author":"A Ophir","year":"1992","unstructured":"Ophir, A. Encapsulated filtering bleb. A selective review\u2014new deductions. Eye 6, 348\u2013352 (1992).","journal-title":"Eye"},{"key":"23150_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1471-4159.2006.03716.x","volume":"97","author":"FA Monteiro","year":"2006","unstructured":"Monteiro, F. A. et al. Activation of ERK1\/2 MAP kinases in familial amyloidotic polyneuropathy. J. Neurochem. 97, 151\u2013161 (2006).","journal-title":"J. Neurochem."},{"key":"23150_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131770","volume":"10","author":"MS Malvankar-Mehta","year":"2015","unstructured":"Malvankar-Mehta, M. S. et al. iStent with phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataract: A meta-analysis. PLoS ONE 10, e0131770 (2015).","journal-title":"PLoS ONE"},{"key":"23150_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ajo.2012.09.023","volume":"155","author":"KS Leonard","year":"2013","unstructured":"Leonard, K. S. et al. Preclinical investigation of ab interno trabeculectomy using a novel dual-blade device. Am. J. Ophthalmol. 155, 524\u2013529 (2013).","journal-title":"Am. J. Ophthalmol."},{"key":"23150_CR19","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1111\/aos.13288","volume":"95","author":"M Tanito","year":"2017","unstructured":"Tanito, M. et al. Short-term results of microhook ab interno trabeculotomy, a novel minimally invasive glaucoma surgery in Japanese eyes: Initial case series. Acta Ophthalmol. 95, e354-360 (2017).","journal-title":"Acta Ophthalmol."},{"key":"23150_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ophtha.2013.11.001","volume":"121","author":"DS Grover","year":"2014","unstructured":"Grover, D. S. et al. Gonioscopy-assisted transluminal trabeculotomy, ab interno trabeculotomy: Technique report and preliminary results. Ophthalmology 121, 855\u2013861 (2014).","journal-title":"Ophthalmology"},{"key":"23150_CR21","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2147\/OPTH.S161238","volume":"12","author":"T Sato","year":"2018","unstructured":"Sato, T., Kawaji, T., Hirata, A. & Mizoguchi, T. 360-degree suture trabeculotomy ab interno to treat open-angle glaucoma: 2-year outcomes. Clin. Ophthalmol. 12, 915\u2013923 (2018).","journal-title":"Clin. Ophthalmol."},{"key":"23150_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2018-000159","volume":"3","author":"T Sato","year":"2018","unstructured":"Sato, T., Kawaji, T., Hirata, A. & Mizoguchi, T. 360-degree suture trabeculotomy ab interno with phacoemulsification in open-angle glaucoma and coexisting cataract: A pilot study. BMJ Open Ophthalmol. 3, e000159 (2018).","journal-title":"BMJ Open Ophthalmol."},{"key":"23150_CR23","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/bjophthalmol-2020-316624","volume":"105","author":"T Sato","year":"2021","unstructured":"Sato, T. & Kawaji, T. 12-month randomised trial of 360\u00b0 and 180\u00b0 Schlemm\u2019s canal incisions in suture trabeculotomy ab interno for open-angle glaucoma. Br. J. Ophthalmol. 105, 1094\u20131098 (2021).","journal-title":"Br. J. Ophthalmol."},{"key":"23150_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","volume":"15","author":"D Adams","year":"2019","unstructured":"Adams, D., Koike, H., Slama, M. & Coelho, T. Hereditary transthyretin amyloidosis: A model of medical progress for a fatal disease. Nat. Rev. Neurol. 15, 387\u2013404 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"23150_CR25","first-page":"497","volume":"31","author":"T Cavallaro","year":"1990","unstructured":"Cavallaro, T. et al. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest. Ophthalmol. Vis. Sci. 31, 497\u2013501 (1990).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"23150_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.exer.2005.02.003","volume":"81","author":"T Kawaji","year":"2005","unstructured":"Kawaji, T. et al. Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp. Eye Res. 81, 306\u2013312 (2005).","journal-title":"Exp. Eye Res."},{"key":"23150_CR27","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3109\/02713688909013902","volume":"8","author":"R Rosenquist","year":"1989","unstructured":"Rosenquist, R. et al. Outflow resistance of enucleated human eyes at two different perfusion pressures and different extents of trabeculotomy. Curr. Eye Res. 8, 1233\u20131240 (1989).","journal-title":"Curr. Eye Res."},{"key":"23150_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100750","volume":"19","author":"NB Barbosa","year":"2020","unstructured":"Barbosa, N. B. & Grippo, T. M. Excisional goniotomy with Kahook Dual Blade in a patient with glaucoma secondary to Transthyretin Amyloidosis. Am. J. Ophthalmol. Case Rep. 19, 100750 (2020).","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"23150_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10384-020-00753-0","volume":"64","author":"S Kakihara","year":"2020","unstructured":"Kakihara, S. et al. Baerveldt glaucoma drainage implant surgery for secondary glaucoma in patients with transthyretin-related familial amyloid polyneuropathy. Jpn. J. Ophthalmol. 64, 533\u2013538 (2020).","journal-title":"Jpn. J. Ophthalmol."},{"key":"23150_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41433-021-01443-y","volume":"36","author":"A Marta","year":"2022","unstructured":"Marta, A. et al. Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis. Eye 36, 111\u2013118 (2022).","journal-title":"Eye"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23150-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23150-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23150-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T15:44:17Z","timestamp":1668181457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23150-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["23150"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-23150-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19330"}}